title: T-cell immunotherapy with a chimeric receptor against CD38 is effective in eradicating chemotherapy-resistant B-cell lymphoma cells overexpressing survivin induced by BMI-1.
authors: J
authors: J
authors: Bhattacharyya
authors: K
authors: K
authors: Mihara
authors: A
authors: A
authors: Kitanaka
authors: K
authors: K
authors: Yanagihara
authors: T
authors: T
authors: Kubo
authors: Y
authors: Y
authors: Takei
authors: A
authors: A
authors: Kimura
authors: Y
authors: Y
authors: Takihara